Association of Molecular Marker Status With Graded Prognostic Assessment of Lung Cancer With Brain Metastases

被引：1
|
作者：
Suh, John H. [1 ,2 ,3 ]
机构：
[1] Cleveland Clin, Dept Radiat Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
来源：
JAMA ONCOLOGY | 2017年 / 3卷 / 06期
关键词：
SURVIVAL;
D O I：
10.1001/jamaoncol.2016.3818
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：831 / 832
页数：3
相关论文
共 50 条
  • [31] Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score
    Jakola, A. S.
    Gulati, S.
    Nerland, U. S.
    Solheim, O.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (03) : 573 - 581
  • [32] Assessment of Prognostic Scores in Brain Metastases from Lung Adnocarcinoma with Status of EGFR Mutations
    Li, Hongwei
    Cao, Jiianzhong
    Zhang, Xiaqin
    Wang, Weili
    Jia, Haixia
    Bai, Wei
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1517 - S1518
  • [33] Correlation between graded prognostic assessment (GPA) and survival in primary lung cancer patients with brain metastases treated with stereotactic radiosurgery
    Lee, H.
    Appel, W.
    Bezecny, P.
    Hindley, A.
    Skailes, G.
    Sivaramalingam, M.
    Lau, S.
    Varadarajan, K.
    Benn, C.
    Abbott, C.
    LUNG CANCER, 2015, 87 : S54 - S54
  • [34] Revised graded prognostic assessment (GPA) index for small cell lung cancer (SCLC) patients (pts) With brain metastases (BM).
    Du, Lingling
    Chao, Samuel T.
    Venur, Vyshak Alva
    Agwa, Eberechi Sandra
    Elson, Paul
    Suh, John H.
    Ahluwalla, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Graded Prognostic Index for Gastroesophageal Cancer with Brain Metastases.
    Karivedu, Vidhya
    Balasubramanian, Suresh Kumar
    Chao, Samuel T.
    Jia, Xuefei
    Elson, Paul
    Ahluwalia, Manmeet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] External validation of modified breast graded prognostic assessment for breast cancer patients with brain metastases
    Griguolo, G.
    Jacot, W.
    Kantelhardt, E.
    Dieci, M. V.
    Bourgier, C.
    Thomssen, C.
    Bailleux, C.
    Miglietta, F.
    Braccini, A. L.
    Conte, P. F.
    Ferrero, J-M.
    Guarneri, V.
    Darlix, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] EFFECT OF TUMOR SUBTYPE ON SURVIVAL AND THE GRADED PROGNOSTIC ASSESSMENT FOR PATIENTS WITH BREAST CANCER AND BRAIN METASTASES
    Sperduto, Paul W.
    Kased, Norbert
    Roberge, David
    Xu, Zhiyuan
    Shanley, Ryan
    Luo, Xianghua
    Sneed, Penny K.
    Chao, Samuel T.
    Weil, Robert J.
    Suh, John
    Bhatt, Amit
    Jensen, Ashley W.
    Brown, Paul D.
    Shih, Helen A.
    Kirkpatrick, John
    Gaspar, Laurie E.
    Fiveash, John B.
    Chiang, Veronica
    Knisely, Jonathan P. S.
    Sperduto, Christina Maria
    Lin, Nancy
    Mehta, Minesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 2111 - 2117
  • [38] Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases
    Fabregat-Franco, C.
    Stradella, A.
    Navarro, V.
    Linares, J.
    Galdeano, M.
    Recalde, S.
    Velasco, R.
    Simo, M.
    Fernadez, A.
    Venthecourt, A. C.
    Falo, C.
    Vazquez, S.
    Bergamino, M.
    Villanueva, R.
    Pernas, S.
    Gil-Gil, M. J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (09): : 1761 - 1768
  • [39] IS THE BREAST CANCER GRADED PROGNOSTIC ASSESSMENT TOOL VALID IN SCOTTISH PATIENTS WITH SECONDARY BRAIN METASTASES?
    Wells, L. A. R.
    Kerr, G.
    MacLennan, M.
    Evans, T. K. A.
    BREAST, 2013, 22 : S45 - S46
  • [40] Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases
    C. Fabregat-Franco
    A. Stradella
    V. Navarro
    J. Linares
    M. Galdeano
    S. Recalde
    R. Velasco
    M. Simo
    A. Fernadez
    A. C. Venthecourt
    C. Falo
    S. Vazquez
    M. Bergamino
    R. Villanueva
    S. Pernas
    M. J. Gil-Gil
    Clinical and Translational Oncology, 2021, 23 : 1761 - 1768
12345